CytoDyn CYDY
OTC CYDY
$0.25 0.00 (-1.77%)
As of: Oct 21, 2026 · 12:21 PM EDT

CytoDyn (CYDY) Non-Current Debt (2012 - 2023)

Updated

CytoDyn's Non-Current Debt was $9,000 in fiscal Q3 2013 (quarter ended Feb 28, 2013).

Analysis

CytoDyn (CYDY) Non-Current Debt (2012 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 CytoDyn 340.03 Mn 291.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2023 714,000.00
May 31, 2014 540,000.00
Feb 28, 2014 457,000.00
Nov 30, 2013 375,000.00
May 31, 2013 291,000.00
Feb 28, 2013 9,000.00
May 31, 2012 9,000.00
API Access

CytoDyn Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CYDY&period=max&api_key=YOUR_API_KEY